The signal that spurs Wall Street into action

It's just rested on an obscure stock

Wall Street funds are pulling heavily out of the Mag 7. Instead, that capital is rotating into a new group of stocks.   And one of the names poised to receive a wave of inflows just triggered a buy signal that has never missed. In my research, every time this signal appeared, the underlying stock didn’t simply grind higher. It launched into a parabolic move as institutional money poured in from Wall Street desks, insiders, and hedge funds. Now, I can’t make absolute guarantees about any trade. But I will be watching this stock very closely over the next couple of weeks. In fact, I’ve already mapped out a game plan to capitalize on any bullish move that develops during that window.   You'll see:   • The rare signal that’s historically preceded explosive moves • Why this setup looks eerily similar right now • And a major announcement tied directly to this trade idea So if you’d like to follow along, the door is open. You can see the complete game plan right here. Trade well,  Jeffry Turnmire

Wall Street funds are pulling heavily out of the Mag 7.   Instead, that capital is rotating into a new group of stocks.   And one of the names poised to receive a wave of inflows just triggered a buy signal that has never missed.   In my research, every time this signal appeared, the underlying stock didn’t simply grind higher.   It launched into a parabolic move as institutional money poured in from Wall Street desks, insiders, and hedge funds.   Now, I can’t make absolute guarantees about any trade.   But I will be watching this stock very closely over the next couple of weeks.   In fact, I’ve already mapped out a game plan to capitalize on any bullish move that develops during that window.   You'll see:   The rare signal that’s historically preceded explosive moves Why this setup looks eerily similar right now And a major announcement tied directly to this trade idea So if you’d like to follow along, the door is open.   You can see the complete game plan right here.   Trade well,    Jeffry Turnmire

ABOUT US:  We believe that the opportunity for financial literacy and freedom belongs to all people, not just those who already have years of investing experience. Jeffry Turnmire Trading provides an array of educational services and products that will help you navigate the markets and become a better investor. Trading is made simple through our online forum full of trading techniques to give you the best tools to kick-start your investing journey. We offer collaborative webinars and training; we love to teach. No matter the opportunity, we bring together a strong community of like-minded traders to focus on analyzing market news as it’s presented each day. DISCLAIMER: FOR INFORMATION PURPOSES ONLY. The materials presented from Jeffry Turnmire Trading are for your informational purposes only. Neither Jeffry Turnmire Trading nor its employees offer investment, legal or tax advice of any kind, and the analysis displayed with various tools does not constitute investment, legal or tax advice and should not be interpreted as such. Using the data and analysis contained in the materials for reasons other than the informational purposes intended is at the user’s own risk. DISCLAIMER: TRADE AT YOUR OWN RISK; TRADING INVOLVES RISK OF LOSS; SEEK PROFESSIONAL ADVICE. Jeffry Turnmire Trading is not responsible for any losses that may occur from transactions effected based upon information or analysis contained in the presented. To the extent that you make use of the concepts with the presentation material, you are solely responsible for the applicable trading or investment decision. Trading activity, including options transactions, can involve the risk of loss, so use caution when entering any option transaction. You trade at your own risk, and it is recommended you consult with a financial advisor for investment, legal or tax advice relating to options transactions.  Please visit https://prosperitypub.com/terms-conditions/ for our full Terms and Conditions. Unsubscribe This email was sent to ahmedwithnour@gmail.com by Prosperity Pub 101 Marketside Ave, Suite 404 PMB 318, Ponte Vedra, Florida 32081, United States Prosperity Pub

ABOUT US:  We believe that the opportunity for financial literacy and freedom belongs to all people, not just those who already have years of investing experience. Jeffry Turnmire Trading provides an array of educational services and products that will help you navigate the markets and become a better investor. Trading is made simple through our online forum full of trading techniques to give you the best tools to kick-start your investing journey. We offer collaborative webinars and training; we love to teach. No matter the opportunity, we bring together a strong community of like-minded traders to focus on analyzing market news as it’s presented each day. DISCLAIMER: FOR INFORMATION PURPOSES ONLY. The materials presented from Jeffry Turnmire Trading are for your informational purposes only. Neither Jeffry Turnmire Trading nor its employees offer investment, legal or tax advice of any kind, and the analysis displayed with various tools does not constitute investment, legal or tax advice and should not be interpreted as such. Using the data and analysis contained in the materials for reasons other than the informational purposes intended is at the user’s own risk. DISCLAIMER: TRADE AT YOUR OWN RISK; TRADING INVOLVES RISK OF LOSS; SEEK PROFESSIONAL ADVICE. Jeffry Turnmire Trading is not responsible for any losses that may occur from transactions effected based upon information or analysis contained in the presented. To the extent that you make use of the concepts with the presentation material, you are solely responsible for the applicable trading or investment decision. Trading activity, including options transactions, can involve the risk of loss, so use caution when entering any option transaction. You trade at your own risk, and it is recommended you consult with a financial advisor for investment, legal or tax advice relating to options transactions.  Please visit https://prosperitypub.com/terms-conditions/ for our full Terms and Conditions. Unsubscribe This email was sent to ahmedwithnour@gmail.com by Prosperity Pub 101 Marketside Ave, Suite 404 PMB 318, Ponte Vedra, Florida 32081, United States Prosperity Pub

Get Ready For Tomorrow: See Why (OGEN) Just Hit Thursday’s Watchlist

Any content you receive is for information purposes only. Always conduct your own research. *Sponsored Oragenics, Inc. (NYSE American: OGEN) Just Hit Krypton Street's Watchlist Heading Today's Session—Thursday, March 12, 2026 Don't Miss The Next Breakout—Get Real-Time Alerts Sent Directly To Your Phone. Up To 10X Faster Than Email. Watch For Our Full Coverage On (OGEN) To Start Early Take A Look At (OGEN) Before Tomorrow Morning… March 11, 2026 Get Ready For Tomorrow | See Why (OGEN) Just Hit Thursday's Watchlist Dear Reader, After today's profile tapped $4.98 in the early session, marking an approximate 27% overnight move before the bell even rang, we're now turning our attention to this next idea that just landed on our radar. Every year, traumatic brain injuries disrupt more lives in America than stroke, Alzheimer's disease, Parkinson's disease, multiple sclerosis, and ALS combined. Yet despite the scale of this growing medical burden, doctors still have no FDA-approved dr-ug specifically for concussions. That has left patients, families, athletes, and military personnel facing a serious treatment gap at the very moment rapid intervention matters most. It has also intensified the search for a therapy that can reach the brain quickly, directly, and safely. Now, one clinical-stage biotech company is working to answer that need in a way few others can. Oragenics, Inc. (NYSE American: OGEN) is advancing a proprietary intranasal delivery technology designed to bypass the blood-brain barrier and deliver treatment directly to the source of neurological injury. And this is just one of the reasons why (OGEN) will be topping our watchlist tomorrow—Thursday, March 12, 2026. But keep in mind, (OGEN) has less than 5M shares listed as available to the public, according to MarketWatch. When companies like this have small public floats, the potential exists for big moves if demand begins to shift. In fact, (OGEN) just made an approximate 79% move over the last month, from around $.62 on February 12 to $1.11 this week, according to data available from Barchart. That underlying medical story is a major part of what makes the company worth watching. With no currently FDA-approved pharmacological treatments for concussions, the company is emerging as a notable name in the evolving field of brain health. Here's a closer look at how Oragenics, Inc. (NYSE American: OGEN)'s platform is designed to address that challenge. Revolutionizing Brain-Targeted Therapeutics Oragenics, Inc. (NYSE American: OGEN) is a clinical-stage biotechnology company dedicated to fighting neurological conditions through its proprietary intranasal delivery platform. The company's lead candidate, ONP-002, is a dr-ug-device combination specifically engineered to deliver neuroprotective compounds directly to the brain via the nasal cavity. This method is designed to provide rapid therapeutic onset while minimizing systemic side effects, a critical factor when treating acute brain trauma. Traditionally, dr-ugs intended for the brain have struggled to cross the blood-brain barrier (BBB), often requiring high systemic doses that lead to unwanted toxicity in other organs. Oragenics aims to circumvent this hurdle entirely. The company is currently focused on the concussion and mild traumatic brain injury (mTBI) market, an area of medicine that has seen little innovation despite its prevalence in sports, military operations, and everyday accidents. Beyond its lead program, Oragenics believes its delivery technology has broad applications for other high-value indications, including Parkinson's disease, Alzheimer's disease, PTSD, and anxiety disorders. By utilizing a "nose-to-brain" route, the company aims to overcome the traditional challenges of oral or intravenous medications that struggle to reach the central nervous system effectively. This unique delivery mechanism could potentially transform how we treat a wide spectrum of chronic and acute neurological pathologies. Addressing a Large and Expanding Market The scale of the nasal dr-ug delivery technology market is substantial, with projections suggesting it will grow from $95B in 2026 to more than $179B by 2035. Within this broader segment, the concussion market is projected to reach $8.58B by 2026 and expand to $10.43B by 2030. (OGEN) is focused on this projected $9B market through the advancement of ONP-002, which the company describes as the first and only clinical-stage pharmacological therapy for concussions and mTBI. With no standardized dr-ug-based treatment currently available for concussions, (OGEN) is working in an area of medicine that remains largely unaddressed. Recent operational milestones have also strengthened the company's forward path. On March 10, 2026, Oragenics announced that it received HREC approval to begin its Phase IIa clinical trial for ONP-002 in Australia. This clearance allows for patient enrollment across three clinical sites, marking an important step from preclinical development into human evaluation. In addition, the company has partnered with DUCK FLATS Pharma to support regulatory readiness for a future FDA Investigational New dr-ug (IND) application in the United States. That collaboration is intended to help align the clinical program with the standards required for a potential U.S. development pathway. Strategic Pipeline and Technical Positioning The technical strength of (OGEN) is bolstered by its strategic partnership with Receptor.AI, an entity that uses artificial intelligence to accelerate pipeline development. This collaboration is intended to identify new therapeutic candidates that can utilize the company's intranasal device, effectively turning Oragenics into a multi-asset platform company rather than a single-product venture. By leveraging AI, the company can scan a vast number of chemical compounds to identify those most likely to treat neurodegeneration when delivered through its proprietary device. From a technical perspective, (OGEN) presents a unique profile with less than 5M shares listed as available to the public. In the world of biotechnology, a small float often means that positive clinical data or regulatory news can lead to rapid adjustments in valuation. Currently sitting around the $1 range, the company appears to be overlooked by the broader market despite its proximity to potential major clinical catalysts. The Q3 2025 shareholder update highlighted a clear vision: moving from the conceptual phase into full-scale execution and clinical validation. As we look at the landscape of 2026, the demand for effective brain health solutions has never been higher. Professional sports leagues, the military, and public health organizations are all searching for a way to mitigate the long-term effects of brain trauma, such as Chronic Traumatic Encephalopathy (CTE). (OGEN) is positioning ONP-002 as the answer to this call. By providing a portable, easy-to-use intranasal device, the company envisions a future where concussions are treated immediately on the sidelines or on the battlefield, potentially preventing the cascade of neurological damage that leads to permanent disability. The management team at (OGEN) has been methodically checking off regulatory boxes. From securing compliance on major exchanges to forming partnerships with top-tier pharmacological consultants, the infrastructure for a major clinical launch is now in place. The company's corporate presentation outlines a roadmap that includes not just the completion of the Australian trials, but a clear path toward global expansion. With the global nasal dr-ug delivery market expanding at a rapid clip, the timing for (OGEN)'s clinical progression couldn't be more fortuitous. 7 Reasons Why (OGEN) Will Be Topping Our Watchlist Tomorrow Morning—Thursday, March 12, 2026… 1. Small Float: With fewer than 5M shares listed as available to the public according to MarketWatch, (OGEN)'s small float could have the potential for big moves if demand begins to shift. 2. Recent Momentum: (OGEN) just made an approximate 79% move over the last month, from around $.62 on February 12 to $1.11 this week 3. Unmet Need: Because there are currently no FDA-approved pharmacological treatments for concussions, (OGEN) is operating in a part of brain health that remains largely unaddressed. 4. Clinical Progress: After receiving HREC approval on March 10, 2026 to begin a Phase IIa clinical trial in Australia across three clinical sites, (OGEN) has moved its lead program into human evaluation. 5. Large Market: By focusing on concussion and mild traumatic brain injury, (OGEN) is targeting a projected $9B segment within the broader nasal delivery technology market expected to grow significantly over the coming decade. 6. AI Partnership: Through its collaboration with Receptor.AI, (OGEN) is using artificial intelligence to screen a large number of compounds and identify new candidates that may work with its proprietary intranasal device. 7. Regulatory Path: With support from DUCK FLATS Pharma to prepare a future FDA IND submission and a roadmap that includes global expansion, (OGEN) has been building the regulatory and operational framework needed for further clinical advancement. Take a Look At (OGEN) Before Tomorrow Morning… As you can see, several key elements are now aligning around Oragenics, Inc. (NYSE American: OGEN). From a public float of fewer than 5M shares to a platform designed to bypass the blood-brain barrier, the company is working in an area of neuroscience that has seen limited progress despite the scale of concussion-related injuries. The recent HREC clearance allowing Phase IIa patient enrollment in Australia marks an important step as the program moves into human evaluation. At the same time, partnerships with Receptor.AI and DUCK FLATS Pharma highlight efforts to expand the pipeline and prepare for future regulatory filings. Taken together, these developments place (OGEN) at an interesting point as its clinical and operational milestones continue to unfold. We will have all eyes on (OGEN) tomorrow morning—Thursday, March 12, 2026. Take a look at (OGEN) before you call it a night. Also, keep a lookout for my morning update. Have a good night. Sincerely, Alex Ramsay Co-Founder / Managing Editor Krypton Street Newsletter   KryptonStreet.com ("KryptonStreet" or "KS" ) is owned by Media 1717 LLC, a single member limited liability company. Data is provided from third-party sources and KS is not responsible for its accuracy. Make sure to always do your own research and due diligence on any day and swing profile KS brings to your attention. Any emojis used do not have a specific defined meaning, and may be used inconsistently. We do not provide personalized in-vest-ment advice, are not in-vest-ment advisors, and any profiles we mention are not suitable for all in-vest-ors. Pursuant to an agreement between Media 1717 LLC and TD Media LLC, Media 1717 LLC has been hired for a period beginning on 03/11/2026 and ending on 03/12/2026 to publicly disseminate information about (OGEN:US) via digital communications. Under this agreement, TD Media LLC has paid Media 1717 LLC seven thousand five hundred USD ("Funds"). To date, including under the previously described agreement, Media 1717 LLC has been paid fifteen thousand one hundred USD ("Funds"). These Funds were part of the fifty two thousand five hundred USD funds that TD Media LLC received from a third party named Sica Media LLC who did not receive the Funds directly or indirectly from the Issuer and does not own stock in the Issuer but the reader should assume that the clients of the third party own shares in the Issuer, which they will liquidate at or near the time you receive this communication and has the potential to hurt share prices. Neither Media 1717 LLC, TD Media LLC and their member own shares of (OGEN:US). Please see important disclosure information here: https://kryptonstreet.com/disclosure/ogen-0jylt/#details

Media 1717 LLC | 6586 W Atlantic Ave, Unit #2086, Delray Beach, FL 33446 Unsubscribe Update Profile | Constant Contact Data Notice Sent by alex@kryptonstreet.com

(Nasdaq: BLNE) Hits The Spotlight And #1 On Our Watchlist (5 Key Potential Catalysts)

A leading digital mortgage innovator is

Any content you receive is for information purposes only. Always conduct your own research. *Sponsored (Nasdaq: BLNE) Hits The Spotlight And #1 On Our Watchlist (5 Key Potential Catalysts) *Click Here To Get Our Alerts Faster Via SMS* March 11th Greetings Readers, A leading digital mortgage innovator is transforming access to home lending through alternative solutions and block-chain-backed equity products designed to reach borrowers beyond traditional standards. The recent announcement by President Trump that Freddie Mac and Fannie Mae will purchase $200Bn in mortgage-backed securities to help lower rates has further energized the housing market, creating new momentum for flexible financing models. Positioned at the intersection of technology and housing, this company is turning complex lending into a seamless, inclusive experience—making it worth a second look for anyone watching where digital finance is headed. And with fewer than 19Mn shares in this profile's listed float, a limited supply suggests the potential for heightened volatility. Mix in an analyst $4.50 target suggesting triple-digit potential upside, and there's little to discuss as to why this Nasdaq breakout idea has taken control of my top watchlist spot: *Beeline Holdings, Inc. (Nasdaq: BLNE)* Beeline is an AI-enabled, digital end-to-end loan platform that provides homeowners and property in-vest-ors with mortgage solutions seamlessly, rapidly and at lower cost. And based on several potential catalysts, (Nasdaq: BLNE) has jumped to the top spot on my watchlist this week. Take a look: #1. A Low Float Could Surround BLNE With Potential Volatility In Moments. #2. A Critical Integration Expands Access To Over 3,100 Mortgage Lenders. #3. Beeline's CEO Shares Positive 2026 Outlook And Future Milestone Targeted. #4. The Company Notches A Major Industry Milestone (Launches Game-Changing Platform). #5. An Analyst Target Suggests Strong Potential Upside From Current Chart Levels. But more on those in a second... Who is Beeline Holdings, Inc. (Nasdaq: BLNE)? Beeline is a rapidly growing FinTech company that owns 100% of an Independent Mortgage Banker, a Title Company, a B2B SaaS products company, and minority stake in an AI sales tools firm. The Home Financing Process Has Barely Evolved for the Digital Age Lengthy 40–60 day close cycle Bloated costs $9–13K average cost per loan Labor-heavy & risky Human capital intensive and error-prone Low satisfaction Customer satisfaction ~30% lower than peer industries Missed opp's Inconvenient fixed business hours Few satisfactory solutions Lack of tools for asset-rich homeowners Beeline Brings True Convenience to Mortgage & Home Equity Operations One of the first home financing platforms born from AI, tailored to the habits and expectations of modern homeowners. End-to-End Tools That Power Home Loans & Home Equity Sales BeelineEQUITY - Unlock Home Equity Without Debt, Banks, or Monthly Payments Built for Asset-Rich, Cash-Light Homeowners Enables fractional sale of home equity to unlock liquidity Fast, Fully Digital Experience Online application, automated approvals, and funding in under 5 business days Long-Term Flexibility No forced buybacks, no usage restrictions, no surprises A Massive Industry Ripe for Reinvention Grab Sources And More: Beeline Presentation. ----- And as I mentioned earlier, (Nasdaq: BLNE) has several potential catalysts going its way. Check them out: #1. BLNE Potential Catalyst - A Low Float Could Surround BLNE With Potential Volatility In Moments. According to info from the Yahoo Finance website, BLNE has a relatively low float. In fact, the website reports this profile to have approximately 18.96Mn shares in its float. Why is that important? It's important on one crucial level. Volatility potential. If the company provides positive news towards the first part of 2026, could it help provide a breakout spark when paired with this volatility potential? ----- #2. BLNE Potential Catalyst - A Critical Integration Expands Access To Over 3,100 Mortgage Lenders. Beeline to Integrate Its Digital Quality Control Platform, BLINKQC, Into Encompass Platform, Expanding Access to Over 3,100 Mortgage Lenders PROVIDENCE, R.I., Feb. 03, 2026 (GLOBE NEWSWIRE) -- via IBN - Beeline Holdings (NASDAQ: BLNE), a fast-growing digital mortgage platform redefining the path to homeownership, today announced it has entered into an agreement with Stellar Innovations to integrate Beeline’s proprietary BLINKQC quality control solution into the Encompass® loan origination system by ICE Mortgage Technology. The integration is expected to be live within approximately 90 days. Encompass is the most widely used loan origination system in the U.S., licensed by approximately 3,100 lenders and relied upon by banks, credit unions, and mortgage bankers—particularly mid- to large-scale institutions. Upon completion, the integration is expected to significantly expand BLINKQC’s distribution footprint across the mortgage industry. ... Read the full article here. ----- #3. BLNE Potential Catalyst - Beeline's CEO Shares Positive 2026 Outlook And Future Milestone Targeted. Beeline CEO Publishes Letter to Shareholders PROVIDENCE, R.I., Jan. 15, 2026 (GLOBE NEWSWIRE) -- via IBN – Beeline Holdings, Inc. (NASDAQ: BLNE), a digital mortgage lender offering conventional mortgage products and alternative mortgage solutions for borrowers who do not meet traditional underwriting standards, alongside home equity products leveraging block-chain-enabled technology, today announced that the Company’s CEO has published a letter to shareholders. Dear Fellow Shareholders: Beeline Holdings delivered on several milestones in 2025, and we enter 2026 with a strong foundation and a differentiated business model, poised for accelerated revenue growth. The Company is leveraging its proprietary AI and technology-driven, multi-product digital mortgage platform—built for scale and positioned to disrupt traditional industry KPIs. This growth will be driven by a renewed focus on Beeline’s core mortgage lending business in an improving market, combined with the integration of block-chain-based products and strategic partnerships. Together, these capabilities power BeelineEquity, one of the industry’s first consumer-facing blockchain products introduced by a mortgage lender. This approach enables Beeline to provide home lending alternatives to the underserved, high-growth segments of the population, including millennials, and those in the gig economy. This differentiated combination places Beeline in a unique competitive position through product offerings that traditional retail mortgage lenders, banks, brokers, and wholesale lenders cannot match while generating margins and net income that outperform the industry benchmarks. ... 2026 Outlook Beeline enters 2026 positioned to scale, targeting higher volumes and stronger overall margins than previous years. Our primary objective is to drive increased transaction activities across our core mortgage business, title operations and BeelineEquity platform. Market dynamics are becoming increasingly favorable. Because a greater proportion of existing mortgages are now priced closer to 6% rather than 3%, declining rates are expected to unlock increase in home sales and cash-out refinancing activity. This dynamic is supported by anticipated bond market outlook, including the recent announcement by President Trump to instruct that Freddie Mac and Fannie Mae to purchase $200Bn in mortgage-backed securities in an effort to lower mortgage rates. This improved environment is expected to directly fuel growth in Beeline’s title business as well. BeelineEquity is strategically focused on the top 20% of U.S. ZIP codes, representing approximately $13Tn in available home equity and facing limited competitive penetration, creating a compelling opportunity for differentiated growth. As a result, Beeline expects a $100Mn annual revenue run rate within 24 months. ... Read the full article here. ----- #4. BLNE Potential Catalyst - The Company Notches A Major Industry Milestone (Launches Game-Changing Platform). Beeline Launches Nation’s First Block-chain-Powered Home Equity Platform — Begins Scaling Nationwide PROVIDENCE, R.I., Oct. 27, 2025 (GLOBE NEWSWIRE) -- via IBN -- (NASDAQ: BLNE) -- Beeline Holdings, Inc. (“Beeline”), the digital mortgage lender built for next-generation homeowners, today announced the successful completion by its subsidiary, Beeline Loans, Inc. of its first round of block-chain-recorded BeelineEquity transactions, marking a major industry milestone as the first U.S. platform to tokenize residential home equity at scale. In its initial rollout, BeelineEquity closed five block-chain-tracked equity transactions, with five more scheduled this month and an additional 25 pre-selected to close before year-end. The company’s rapid adoption signals strong homeowner demand for an alternative to traditional home equity loans and refinances. ... “Homeowners shouldn’t have to borrow against themselves just to access the value they’ve already built,” said Nick Liuzza, Co-Founder and CEO of Beeline. “By putting home equity on block-chain rails, we’re creating a smarter, more transparent financial alternative — one that’s free from interest rate swings and credit friction.” ... Read the full article here. ----- #5. BLNE Potential Catalyst - An Analyst Target Suggests Strong Potential Upside From Current Chart Levels. Back in December, Ladenburg Thalmann continued coverage with an "Upgrade" on Beeline Holdings Inc. (Nasdaq: BLNE) and a $4.50 price target. From Wednesday's closing valuation, that target provides BLNE with a potential upside of over 50%! Here are highlights from their 2025 report: A stable coin backed cash-out equity innovation offers significant room for growth. In late June, Beeline announced an innovative new product where homeowners can tap their home value by selling an equity stake to in-vest-ors. This transaction carries a cost of capital about in-line with HELOCs or cash-out refinancing. The benefit is that by selling equity instead of taking on debt instruments the homeowner will not have to service the debt through monthly payments. Beeline's business model is to take a fee for brokering the transaction and likely providing title insurance services. The funding will come from a third-party entity which will issue a stable coin backed by the pool of equity ownership interests. We expect high interest in both this offering and in the third-party issued stable coin. Valuation: We use a set of peers in the real-estate technology sector to determine a market multiple of 3.1x revenue. We apply this multiple to our 2026 estimate to determine our $4.50 price target and our Buy rating. ----- (Nasdaq: BLNE) Recap - These 5 Potential Catalysts Create A Compelling Story! #1. A Low Float Could Surround BLNE With Potential Volatility In Moments. #2. A Critical Integration Expands Access To Over 3,100 Mortgage Lenders. #3. Beeline's CEO Shares Positive 2026 Outlook And Future Milestone Targeted. #4. The Company Notches A Major Industry Milestone (Launches Game-Changing Platform). #5. An Analyst Target Suggests Strong Potential Upside From Current Chart Levels. ----- Coverage is kicked-off on Beeline Holdings, Inc. (Nasdaq: BLNE). As soon as updates are available, we'll send them out quickly. Talk again soon. Sincerely, Kai Parker StockWireNews (Always Remember The St-ock Prices Could Be Significantly Lower Now From The Dates I Provided.)

SWN Media | 160 W. Camino Real Unit 886 | Boca Raton, FL 33432 US Unsubscribe | Update Profile | Constant Contact Data Notice